Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126757131 | 12675713 | 1 | I | 20160406 | 20160823 | 20160823 | PER | US-JAZZ-2016-US-006577 | JAZZ | 0.00 | M | Y | 0.00000 | 20160823 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126757131 | 12675713 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.5 G, BID | 21196 | 2.5 | G | ORAL SOLUTION | |||||||
| 126757131 | 12675713 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 126757131 | 12675713 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 126757131 | 12675713 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | ||||||||||
| 126757131 | 12675713 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 126757131 | 12675713 | 6 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126757131 | 12675713 | 7 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | UNK | 0 | |||||||||||
| 126757131 | 12675713 | 8 | C | BUSPIRONE HCL | BUSPIRONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126757131 | 12675713 | 9 | C | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126757131 | 12675713 | 10 | C | PROVIGIL | MODAFINIL | 1 | U | 0 | |||||||||||
| 126757131 | 12675713 | 11 | C | XANAX | ALPRAZOLAM | 1 | U | 0 | |||||||||||
| 126757131 | 12675713 | 12 | C | NUVIGIL | ARMODAFINIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126757131 | 12675713 | 1 | Hypersomnia |
| 126757131 | 12675713 | 6 | Product used for unknown indication |
| 126757131 | 12675713 | 7 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126757131 | 12675713 | Intentional product use issue | |
| 126757131 | 12675713 | Nausea | |
| 126757131 | 12675713 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126757131 | 12675713 | 1 | 201210 | 201211 | 0 | |
| 126757131 | 12675713 | 2 | 201211 | 2012 | 0 | |
| 126757131 | 12675713 | 3 | 201305 | 201306 | 0 | |
| 126757131 | 12675713 | 4 | 2013 | 2013 | 0 | |
| 126757131 | 12675713 | 5 | 201307 | 0 | ||
| 126757131 | 12675713 | 6 | 20121026 | 20160406 | 0 | |
| 126757131 | 12675713 | 7 | 20150202 | 20160406 | 0 |